RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @pedschwartzmann: Another piece in the #hyperkalemia puzzle in #heartfailure ! @JACCJournals https://t.co/YFG1McNwYf
RT @ATRIUMRx: ICYMI in @JACCJournals, overreacting to transient hyperkalemia in ADHF is common and holding/decreasing the dose of RAS inhib…
Another piece in the #hyperkalemia puzzle in #heartfailure ! @JACCJournals
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @ATRIUMRx: ICYMI in @JACCJournals, overreacting to transient hyperkalemia in ADHF is common and holding/decreasing the dose of RAS inhib…
This 👇🏻👇🏻👇🏻👇🏻. In #HF don’t stop MRA therapy...
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @DrJasper1: Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down ti…
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @AndrewJSauer: Same lesson reinforced: restore MRA and #GDMT before discharge. De escalation of therapies is a marker of increased risk…
RT @ATRIUMRx: ICYMI in @JACCJournals, overreacting to transient hyperkalemia in ADHF is common and holding/decreasing the dose of RAS inhib…
ICYMI in @JACCJournals, overreacting to transient hyperkalemia in ADHF is common and holding/decreasing the dose of RAS inhibitors may worsen long-term outcomes: https://t.co/zv94TxZ8Dt https://t.co/Ql5IIhXsiZ
RT @AndrewJSauer: Same lesson reinforced: restore MRA and #GDMT before discharge. De escalation of therapies is a marker of increased risk…
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @AndrewJSauer: Same lesson reinforced: restore MRA and #GDMT before discharge. De escalation of therapies is a marker of increased risk…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
Same lesson reinforced: restore MRA and #GDMT before discharge. De escalation of therapies is a marker of increased risk for death and deterioration. #GDMTWorks @gcfmd @JJheart_doc @IAmDrIbrahim @JonathanDavisHF @gmac78 @AminYehyaMD @ajaysmd @Abraham_Jacob
RT @JonathanDavisHF: Things a #HeartFailure provider never wants to hear: "Defer spironolactone to outpatient." #GDMTWorks #TipsForNewDocs…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
Our paper just got published in @JACCJournals: hyperkalemia during hospitalization for #heartfailure associated with down titration or discontinuation of RAAS-inhibitors, but did not interfere with treatment benefit.
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JonathanDavisHF: Things a #HeartFailure provider never wants to hear: "Defer spironolactone to outpatient." #GDMTWorks #TipsForNewDocs…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JonathanDavisHF: Things a #HeartFailure provider never wants to hear: "Defer spironolactone to outpatient." #GDMTWorks #TipsForNewDocs…
RT @JonathanDavisHF: Things a #HeartFailure provider never wants to hear: "Defer spironolactone to outpatient." #GDMTWorks #TipsForNewDocs…
Things a #HeartFailure provider never wants to hear: "Defer spironolactone to outpatient." #GDMTWorks #TipsForNewDocs @MKIttlesonMD @AminYehyaMD @AndrewJSauer @SusanJosephMD @mpsotka @IAmDrIbrahim @yaleHFdoc https://t.co/dhrwxfxdHL
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @DevinMehta: One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back…
One of my many pet peaves, “defer ACE-I/ARB/ARNI due to prior hyperkalemia.” It’s perpetuated in notes, yet I trend K back & see many normal values.
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
RT @InternaUninorte: Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @InternaUninorte: Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @JACCJournals: Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approa…
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality https://t.co/1kVlnyTYZy
Fear of #hyperkalemia may lead to failure to deliver guideline-recommended doses of RAAS inhibitors. How should we approach #heartfailure patients at risk for hyperkalemia? This month's #JACCHF presents optimal treatments for this patient population. https
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
一方、入院後アルド拮抗薬減量 [やむない] 例では180日死亡HRが1.73 [95%CI 1.15-2.80]。逆に、MRA、RAS-i 増量 [可能] 例では、有意に低。 https://t.co/MP1Jm9TmBC https://t.co/AzFeXhEQzi
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @GiuseppeGalati_: Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing…
PROTECT Study in pts hospitalized with acute #HF evaluated association of #hyperkalemia and #RAASi changes. Those who decreased or discontinued the #ACEI #ARB dose were associated with higher 180-day mortality risk compared to those with constant dose. ht
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
Dear @novitskiynic thank for sharing this important paper. Congrats to Prof @MarcoMetra & all the authors for focusing on the problem of Hyperkalemia limiting optimization of #HF therapies during hospitalization. New drugs at the Horizon for solving th
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
RT @novitskiynic: 🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underus…
🛡PROTECT study by Beusekamp and co-authors in @JACCJournals •HyperK in Acute HF are often •It’s associated with underuse of MRAs-⤴️risk of mortality at 180days •Constant doses or up-titration of MRAs and/or ACE/ARB still benefits despite hyperK 📎 https
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
RT @aishaikh: Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https:/…
Link to the articles ⚡️Acute GFR ⬇️& ACE-Inh. in ❤️ Failure 👉🏽 https://t.co/cCNCrxSnB5 ⚡️White Coat & Masked HTN 👉🏽 https://t.co/gxYT7bUXp1 ⚡️Hyponatremia & Hypernatremia 👉🏽 https://t.co/NAoLXapczt ⚡️⬆️K w/ RAAS-Inh in ❤️ Failure 👉🏽 https://